Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126458602 | 12645860 | 2 | F | 20160705 | 20160811 | 20160811 | PER | US-ENDO PHARMACEUTICALS INC.-2016-004365 | ENDO | 0.00 | M | Y | 0.00000 | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126458602 | 12645860 | 1 | PS | PREDNISONE TABLETS | PREDNISONE | 1 | Unknown | U | 40256 | UNKNOWN | |||||||||
| 126458602 | 12645860 | 2 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 0 | 160 | MG | CAPSULE | QD | |||||||
| 126458602 | 12645860 | 3 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 0 | 160 | MG | CAPSULE | QD | |||||||
| 126458602 | 12645860 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 5 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 6 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 7 | C | METAMUCIL | PLANTAGO SEED | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 8 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 10 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 11 | C | CURCUMIN | CURCUMIN | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 12 | C | GINGER. | GINGER | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 13 | C | FENTANYL. | FENTANYL | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 14 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | 0 | ||||||||||||
| 126458602 | 12645860 | 15 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126458602 | 12645860 | 1 | Product used for unknown indication |
| 126458602 | 12645860 | 2 | Prostate cancer |
| 126458602 | 12645860 | 4 | Product used for unknown indication |
| 126458602 | 12645860 | 5 | Product used for unknown indication |
| 126458602 | 12645860 | 6 | Product used for unknown indication |
| 126458602 | 12645860 | 7 | Product used for unknown indication |
| 126458602 | 12645860 | 8 | Product used for unknown indication |
| 126458602 | 12645860 | 9 | Product used for unknown indication |
| 126458602 | 12645860 | 10 | Product used for unknown indication |
| 126458602 | 12645860 | 11 | Product used for unknown indication |
| 126458602 | 12645860 | 12 | Product used for unknown indication |
| 126458602 | 12645860 | 13 | Product used for unknown indication |
| 126458602 | 12645860 | 14 | Product used for unknown indication |
| 126458602 | 12645860 | 15 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126458602 | 12645860 | Decreased appetite | |
| 126458602 | 12645860 | Fatigue | |
| 126458602 | 12645860 | Feeling abnormal | |
| 126458602 | 12645860 | Headache | |
| 126458602 | 12645860 | Hyperhidrosis | |
| 126458602 | 12645860 | Nausea | |
| 126458602 | 12645860 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126458602 | 12645860 | 2 | 20160524 | 0 |